Cell Cycle-Regulated Protein Abundance Changes in Synchronously Proliferating HeLa Cells Include Regulation of Pre-mRNA Splicing Proteins

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Lane, Karen R ^a   Yu, Yanbao ^b   Lackey, Patrick E ^b   Chen, Xian ^a,b   Marzluff, William F ^a   Cook, Jeanette Gowen ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN 6; MESSENGER RNA; RIBONUCLEOPROTEIN;

ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DNA REPLICATION; DOWN REGULATION; HELA CELL; HUMAN; HUMAN CELL; MITOSIS; PHASE TRANSITION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEOMICS; RNA SPLICING; UBIQUITINATION;

CELL CYCLE; HELA CELLS; HUMANS; PHOSPHORYLATION; PROTEOME; PROTEOMICS; RNA PRECURSORS; UBIQUITINATION;

EID: 84874760133     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058456     Document Type: Article

References (67)

1. Arentson E, Faloon P, Seo J, Moon E, Studts JM, et al. (2002) Oncogenic potential of the DNA replication licensing protein CDT1. Oncogene 21: 1150-1158.
2. Karakaidos P, Taraviras S, Vassiliou LV, Zacharatos P, Kastrinakis NG, et al. (2004) Overexpression of the replication licensing regulators hCdt1 and hCdc6 characterizes a subset of non-small-cell lung carcinomas: synergistic effect with mutant p53 on tumor growth and chromosomal instability-evidence of E2F-1 transcriptional control over hCdt1. Am J Pathol 165: 1351-1365.
3. Xouri G, Lygerou Z, Nishitani H, Pachnis V, Nurse P, et al. (2004) Cdt1 and geminin are down-regulated upon cell cycle exit and are over-expressed in cancer-derived cell lines. Eur J Biochem 271: 3368-3378.
4. Liontos M, Koutsami M, Sideridou M, Evangelou K, Kletsas D, et al. (2007) Deregulated overexpression of hCdt1 and hCdc6 promotes malignant behavior. Cancer Res 67: 10899-10909.
5. Bell SP, Dutta A, (2002) DNA replication in eukaryotic cells. Annu Rev Biochem 71: 333-374.
6. Cho RJ, Huang M, Campbell MJ, Dong H, Steinmetz L, et al. (2001) Transcriptional regulation and function during the human cell cycle. Nat Genet 27: 48-54.
7. Whitfield ML, Sherlock G, Saldanha AJ, Murray JI, Ball CA, et al. (2002) Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol Biol Cell 13: 1977-2000.
8. Olsen JV, Vermeulen M, Santamaria A, Kumar C, Miller ML, et al. (2010) Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal 3: ra3.
9. Takahashi Y, Rayman JB, Dynlacht BD, (2000) Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. Genes Dev 14: 804-816.
10. Shevchenko A, Tomas H, Havlis J, Olsen JV, Mann M, (2006) In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 1: 2856-2860.
11. Cox J, Mann M, (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 26: 1367-1372.
12. Cox J, Neuhauser N, Michalski A, Scheltema RA, Olsen JV, et al. (2011) Andromeda: a peptide search engine integrated into the MaxQuant environment. J Proteome Res 10: 1794-1805.
13. Gauthier NP, Larsen ME, Wernersson R, de Lichtenberg U, Jensen LJ, et al. (2008) Cyclebase.org-a comprehensive multi-organism online database of cell-cycle experiments. Nucleic Acids Res 36: D854-859.
14. Gauthier NP, Jensen LJ, Wernersson R, Brunak S, Jensen TS, (2009) Cyclebase.org: version 2.0, an updated comprehensive, multi-species repository of cell cycle experiments and derived analysis results. Nucleic Acids Res 38: D699-702.
15. Kim W, Bennett EJ, Huttlin EL, Guo A, Li J, et al. (2011) Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell 44: 325-340.
16. Stokes MP, Rush J, Macneill J, Ren JM, Sprott K, et al. (2007) Profiling of UV-induced ATM/ATR signaling pathways. Proc Natl Acad Sci U S A 104: 19855-19860.
17. Chi Y, Welcker M, Hizli AA, Posakony JJ, Aebersold R, et al. (2008) Identification of CDK2 substrates in human cell lysates. Genome Biol 9: R149.
18. Boisvert FM, Ahmad Y, Gierlinski M, Charriere F, Lamont D, et al. (2012) A quantitative spatial proteomics analysis of proteome turnover in human cells. Mol Cell Proteomics 11: M111 011429.
19. Huang dW, Sherman B, Lempicki R, (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37: 1-13.
20. Huang dW, Sherman B, Lempicki R, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
21. Cook JG, Chasse DA, Nevins JR, (2004) The regulated association of Cdt1 with minichromosome maintenance proteins and Cdc6 in mammalian cells. J Biol Chem 279: 9625-9633.
22. Wang ZF, Whitfield ML, Ingledue TC, 3rd, Dominski Z, Marzluff WF, (1996) The protein that binds the 3' end of histone mRNA: a novel RNA-binding protein required for histone pre-mRNA processing. Genes Dev 10: 3028-3040.
23. Fischer RS, Fritz-Six KL, Fowler VM, (2003) Pointed-end capping by tropomodulin3 negatively regulates endothelial cell motility. J Cell Biol 161: 371-380.
24. Chen X, Smith LM, Bradbury EM, (2000) Site-specific mass tagging with stable isotopes in proteins for accurate and efficient protein identification. Anal Chem 72: 1134-1143.
25. Zhu H, Pan S, Gu S, Bradbury EM, Chen X, (2002) Amino acid residue specific stable isotope labeling for quantitative proteomics. Rapid Commun Mass Spectrom 16: 2115-2123.
26. Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, et al. (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1: 376-386.
27. King RW, Peters JM, Tugendreich S, Rolfe M, Hieter P, et al. (1995) A 20S complex containing CDC27 and CDC16 catalyzes the mitosis-specific conjugation of ubiquitin to cyclin B. Cell. 81: 279-288.
28. Petersen BO, Wagener C, Marinoni F, Kramer ER, Melixetian M, et al. (2000) Cell cycle- and cell growth-regulated proteolysis of mammalian CDC6 is dependent on APC-CDH1. Genes Dev 14: 2330-2343.
29. McGarry TJ, Kirschner MW, (1998) Geminin, an inhibitor of DNA replication, is degraded during mitosis. Cell 93: 1043-1053.
30. Sudakin V, Ganoth D, Dahan A, Heller H, Hershko J, et al. (1995) The cyclosome, a large complex containing cyclin-selective ubiquitin ligase activity, targets cyclins for destruction at the end of mitosis. Mol Biol Cell 6: 185-197.
31. Nishitani H, Sugimoto N, Roukos V, Nakanishi Y, Saijo M, et al. (2006) Two E3 ubiquitin ligases, SCF-Skp2 and DDB1-Cul4, target human Cdt1 for proteolysis. Embo J 25: 1126-1136.
32. Jin J, Arias EE, Chen J, Harper JW, Walter JC, (2006) A family of diverse Cul4-Ddb1-interacting proteins includes Cdt2, which is required for S phase destruction of the replication factor Cdt1. Mol Cell 23: 709-721.
33. Arias EE, Walter JC, (2006) PCNA functions as a molecular platform to trigger Cdt1 destruction and prevent re-replication. Nat Cell Biol 8: 84-90.
34. Senga T, Sivaprasad U, Zhu W, Park JH, Arias EE, et al. (2006) PCNA is a cofactor for Cdt1 degradation by CUL4/DDB1-mediated N-terminal ubiquitination. J Biol Chem 281: 6246-6252.
35. Hu J, Xiong Y, (2006) An evolutionarily conserved function of proliferating cell nuclear antigen for Cdt1 degradation by the Cul4-Ddb1 ubiquitin ligase in response to DNA damage. J Biol Chem 281: 3753-3756.
36. Zheng L, Dominski Z, Yang XC, Elms P, Raska CS, et al. (2003) Phosphorylation of stem-loop binding protein (SLBP) on two threonines triggers degradation of SLBP, the sole cell cycle-regulated factor required for regulation of histone mRNA processing, at the end of S phase. Mol Cell Biol 23: 1590-1601.
37. Koseoglu MM, Graves LM, Marzluff WF, (2008) Phosphorylation of threonine 61 by cyclin a/Cdk1 triggers degradation of stem-loop binding protein at the end of S phase. Mol Cell Biol 28: 4469-4479.
38. Koseoglu MM, Dong J, Marzluff WF, (2010) Coordinate regulation of histone mRNA metabolism and DNA replication: cyclin A/cdk1 is involved in inactivation of histone mRNA metabolism and DNA replication at the end of S phase. Cell Cycle 9: 3857-3863.
39. Nagaraj N, Wisniewski JR, Geiger T, Cox J, Kircher M, et al. (2011) Deep proteome and transcriptome mapping of a human cancer cell line. Mol Syst Biol 7: 548.
40. Tsubuki S, Kawasaki H, Saito Y, Miyashita N, Inomata M, et al. (1993) Purification and characterization of a Z-Leu-Leu-Leu-MCA degrading protease expected to regulate neurite formation: a novel catalytic activity in proteasome. Biochem Biophys Res Commun 196: 1195-1201.
41. Tsubuki S, Saito Y, Tomioka M, Ito H, Kawashima S, (1996) Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine. J Biochem 119: 572-576.
42. Wagner SA, Beli P, Weinert BT, Nielsen ML, Cox J, et al. (2011) A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics 10: M111 013284.
43. Chabes AL, Bjorklund S, Thelander L, (2004) S Phase-specific transcription of the mouse ribonucleotide reductase R2 gene requires both a proximal repressive E2F-binding site and an upstream promoter activating region. J Biol Chem 279: 10796-10807.
44. Chabes A, Thelander L, (2000) Controlled protein degradation regulates ribonucleotide reductase activity in proliferating mammalian cells during the normal cell cycle and in response to DNA damage and replication blocks. J Biol Chem 275: 17747-17753.
45. Chabes AL, Pfleger CM, Kirschner MW, Thelander L, (2003) Mouse ribonucleotide reductase R2 protein: a new target for anaphase-promoting complex-Cdh1-mediated proteolysis. Proc Natl Acad Sci U S A 100: 3925-3929.
46. Dart DA, Adams KE, Akerman I, Lakin ND, (2004) Recruitment of the cell cycle checkpoint kinase ATR to chromatin during S-phase. J Biol Chem 279: 16433-16440.
47. Hegele A, Kamburov A, Grossmann A, Sourlis C, Wowro S, et al. (2012) Dynamic protein-protein interaction wiring of the human spliceosome. Mol Cell 45: 567-580.
48. Zhu J, Mayeda A, Krainer AR, (2001) Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins. Mol Cell 8: 1351-1361.
49. Lam BJ, Hertel KJ, (2002) A general role for splicing enhancers in exon definition. RNA 8: 1233-1241.
50. House AE, Lynch KW, (2006) An exonic splicing silencer represses spliceosome assembly after ATP-dependent exon recognition. Nat Struct Mol Biol 13: 937-944.
51. Martinez-Contreras R, Fisette JF, Nasim FU, Madden R, Cordeau M, et al. (2006) Intronic binding sites for hnRNP A/B and hnRNP F/H proteins stimulate pre-mRNA splicing. PLoS Biol 4: e21.
52. Molina H, Horn DM, Tang N, Mathivanan S, Pandey A, (2007) Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry. Proc Natl Acad Sci U S A 104: 2199-2204.
53. Imami K, Sugiyama N, Kyono Y, Tomita M, Ishihama Y, (2008) Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column. Anal Sci 24: 161-166.
54. Cantin GT, Yi W, Lu B, Park SK, Xu T, et al. (2008) Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis. J Proteome Res 7: 1346-1351.
55. Daub H, Olsen JV, Bairlein M, Gnad F, Oppermann FS, et al. (2008) Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle. Mol Cell 31: 438-448.
56. Dephoure N, Zhou C, Villen J, Beausoleil SA, Bakalarski CE, et al. (2008) A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A 105: 10762-10767.
57. Gauci S, Helbig AO, Slijper M, Krijgsveld J, Heck AJ, et al. (2009) Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach. Anal Chem 81: 4493-4501.
58. Mayya V, Lundgren DH, Hwang SI, Rezaul K, Wu L, et al. (2009) Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci Signal 2: ra46.
59. Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, et al. (2009) Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325: 834-840.
60. Matlin AJ, Clark F, Smith CW, (2005) Understanding alternative splicing: towards a cellular code. Nat Rev Mol Cell Biol 6: 386-398.
61. Adamson B, Smogorzewska A, Sigoillot FD, King RW, Elledge SJ, (2012) A genome-wide homologous recombination screen identifies the RNA-binding protein RBMX as a component of the DNA-damage response. Nat Cell Biol 14: 318-328.
62. Dery KJ, Gaur S, Gencheva M, Yen Y, Shively JE, et al. (2011) Mechanistic control of carcinoembryonic antigen-related cell adhesion molecule-1 (CEACAM1) splice isoforms by the heterogeneous nuclear ribonuclear proteins hnRNP L, hnRNP A1, and hnRNP M. J Biol Chem. 286: 16039-16051.
63. Wang Y, Ma M, Xiao X, Wang Z, (2012) Intronic splicing enhancers, cognate splicing factors and context-dependent regulation rules. Nat Struct Mol Biol 19: 1044-1052.
64. Huelga SC, Vu AQ, Arnold JD, Liang TY, Liu PP, et al. (2012) Integrative genome-wide analysis reveals cooperative regulation of alternative splicing by hnRNP proteins. Cell Rep 1: 167-178.
65. McCormack PL (2012) Carfilzomib: In Relapsed, or Relapsed and Refractory, Multiple Myeloma. Drugs.
66. Vij R, Siegel DS, Jagannath S, Jakubowiak AJ, Stewart AK, et al. (2012) An open-label, single-arm, phase 2 study of single-agent carfilzomib in patients with relapsed and/or refractory multiple myeloma who have been previously treated with bortezomib. Br J Haematol 158: 739-748.
67. Han YH, Moon HJ, You BR, Park WH, (2009) The effect of MG132, a proteasome inhibitor on HeLa cells in relation to cell growth, reactive oxygen species and GSH. Oncol Rep 22: 215-221.